Telomere-based risk models for the early diagnosis of clinically significant prostate cancer.
- DOI
- 10.1038/s41391-020-0232-4
- Published
- 2021 Mar
- Container
- Prostate cancer and prostatic diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41391-020-0232-4,
title = {Telomere-based risk models for the early diagnosis of clinically significant prostate cancer.},
author = {Rubio Galisteo JM and Fernández L and Gómez Gómez E and de Pedro N and Cano Castiñeira R and Pedregosa AB and Guler I and Carrasco Valiente J and Esteban L and González S and Castelló N and Otero L and García J and Segovia E and Requena Tapia MJ and Najarro P},
year = {2021},
journal = {Prostate cancer and prostatic diseases},
doi = {10.1038/s41391-020-0232-4},
url = {https://doi.org/10.1038/s41391-020-0232-4}
}RIS
TY - JOUR TI - Telomere-based risk models for the early diagnosis of clinically significant prostate cancer. AU - Rubio Galisteo JM AU - Fernández L AU - Gómez Gómez E AU - de Pedro N AU - Cano Castiñeira R AU - Pedregosa AB AU - Guler I AU - Carrasco Valiente J AU - Esteban L AU - González S AU - Castelló N AU - Otero L AU - García J AU - Segovia E AU - Requena Tapia MJ AU - Najarro P PY - 2021 JO - Prostate cancer and prostatic diseases DO - 10.1038/s41391-020-0232-4 UR - https://doi.org/10.1038/s41391-020-0232-4 ER -
APA
JM, R. G., L, F., E, G. G., N, D. P., R, C. C., AB, P., I, G., J, C. V., L, E., S, G., N, C., L, O., J, G., E, S., MJ, R. T., & P, N. (2021). Telomere-based risk models for the early diagnosis of clinically significant prostate cancer.. Prostate cancer and prostatic diseases. https://doi.org/10.1038/s41391-020-0232-4
Source records
- pubmed · retrieved 2026-09-26T17:10:15.272Z
- europe-pmc · retrieved 2026-09-26T17:10:15.288Z